Answers are grounded in this paper and cite their sources.
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action.
No takes yet. Share an insight, caveat, or question.
Cockburn et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: